Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients

HIGHLIGHTS

  • who: Giovanni Caocci from the Center, RBinaghi Hospital, University of Cagliari, Ospedale “RBinaghi”, Via Guadazzonis, , Cagliari, Italy have published the Article: Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients, in the Journal: (JOURNAL)

SUMMARY

    A complete molecular response was defined as undetectable breakpoint cluster region-Abelson (BCR/ABL1) by real-time quantitative polymerase_chain_reaction (qRTPCR) with a sensitivity of the assay corresponding to molecular response (MR)4 and MR4.5. In these Age at diagnosis (mean, range) Leukocytes at diagnosis ×103/uL (mean, range) ns Platelets at diagnosis . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?